Atresia das vias biliares

Referências

Principais artigos

Bezerra JA, Wells RG, Mack CL, et al. Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century. Hepatology. 2018 Sep;68(3):1163-1173.Texto completo  Resumo

Shneider BL, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148:467-474. Resumo

Artigos de referência

1. Ohi R, Masaki N. The jaundiced infant: biliary atresia and other obstructions. In: O'Neill JA, Rowe MI, Grosfeld JL, et al, eds. Pediatric surgery, 5th ed. St Louis, MO: Mosby; 1998:1465-1482.

2. Balistreri WF, Grand R, Hoofnagle JH, et al. Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology. 1996 Jun;23(6):1682-92.Texto completo  Resumo

3. Harpavat S, Garcia-Prats JA, Shneider BL. Newborn Bilirubin Screening for Biliary Atresia. N Engl J Med. 2016 Aug 11;375(6):605-6.Texto completo  Resumo

4. Silveira TR, Salzano FM, Howard ER, et al. Congenital structural abnormalities in biliary atresia: evidence for etiopathogenic heterogeneity and therapeutic implications. Acta Paediatr Scand. 1991;80:1192-1199. Resumo

5. Karrer FM, Hall RJ, Lilly JR. Biliary atresia and the polysplenia syndrome. J Pediatr Surg. 1991;26:524-527. Resumo

6. Jacquemin E, Cresteil D, Raynaud N, et al. CFCI gene mutation and biliary atresia with polysplenia syndrome. J Pediatr Gastroenterol Nutr. 2002;34:326-327. Resumo

7. Kataria R, Kataria A, Gupta DK. Spectrum of congenital anomalies associated with biliary atresia. Indian J Pediatr. 1996;63:651-654. Resumo

8. Casey B. Genetics of human situs abnormalities. Am J Med Genet. 2001;101:356-358. Resumo

9. Davenport M, Tizzard SA, Underhill J, et al. The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr. 2006;149:393-400. Resumo

10. Chardot C. Biliary atresia. Orphanet J Rare Dis. 2006;1:28.Texto completo

11. Wang SH, Chen CL, Concejero A, et al. Living donor liver transplantation for biliary atresia. Chang Gung Med J. 2007;30:103-108. Resumo

12. Wada H, Muraji T, Yokoi A, et al. Insignificant seasonal and geographical variation in incidence of biliary atresia in Japan: a regional survey of over 20 years. J Ped Surg. 2007;42:2090-2092. Resumo

13. Tiao MM, Tsai SS, Kuo HW, et al. Epidemiological features of biliary atresia in Taiwan, a national study 1996-2003. J Gastroent Hepatol. 2008;23:62-66. Resumo

14. Schreiber RA, Kleinman RE. Genetics, immunology, and biliary atresia: an opening or a diversion? J Pediatr Gastroenterol Nutr. 1993;16:111-113. Resumo

15. Yoon PW, Bresee JS, Olney RS, et al. Epidemiology of biliary atresia: a population-based study. Pediatrics. 1997;99:376-382. Resumo

16. Sokol RJ, Mack C, Narkewicz MR, et al. Pathogenesis and outcome of biliary atresia: current concepts. J Pediatr Gastroenterol Nutr. 2003;37:4-21. Resumo

17. Ayas MF, Hillemeier AC, Olson AD. Lack of evidence for seasonal variation in extrahepatic biliary atresia during infancy. J Clin Gastroenterol. 1996;22:292-294. Resumo

18. Caton AR, Druschel CM, McNutt LA. The epidemiology of extrahepatic biliary atresia in New York State, 1983-98. Paediatr Perinat Epidemiol. 2004;18:97-105. Resumo

19. Smith BM, Laberge JM, Schreiber R, et al. Familial biliary atresia in three siblings including twins. J Pediatr Surg. 1991;26:1331-1333. Resumo

20. Bezerra JA, Wells RG, Mack CL, et al. Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century. Hepatology. 2018 Sep;68(3):1163-1173.Texto completo  Resumo

21. Morecki R, Glaser JH, Cho S, et al. Biliary atresia and reovirus type 3 infection. N Engl J Med. 1984;310:1610. Resumo

22. Morecki R, Glaser JH, Cho S, et al. Biliary atresia and reovirus type 3 infection. N Engl J Med. 1982;307:481-484. Resumo

23. Morecki R, Glaser JH, Johson AB, et al. Detection of reovirus type 3 in the porta hepatis of an infant with extrahepatic biliary atresia: ultrastructural and immunocytochemical study. Hepatology. 1984;4:1137-1142. Resumo

24. Glaser JH, Balistreri WF, Morecki R. Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr. 1984;105:912-915. Resumo

25. Brown WR, Sokol RJ, Levin MJ, et al. Lack of correlation between infection with reovirus 3 and extrahepatic biliary atresia or neonatal hepatitis. J Pediatr. 1988;113:670-676. Resumo

26. Bangaru B, Morecki R, Glaser JH, et al. Comparative studies of biliary atresia in the human newborn and reovirus-induced cholangitis in weanling mice. Lab Invest. 1980;43:456-462. Resumo

27. Stanley NF, Joske RA. Animal model of human disease. Chronic biliary obstruction. Animal model: chronic biliary obstruction caused by reovirus type 3. Am J Pathol. 1975;80:185-188.Texto completo  Resumo

28. Rosenberg DP, Morecki R, Lollini LO, et al. Extrahepatic biliary atresia in a rhesus monkey (Macaca mulatta). Hepatology. 1983;3:577-580. Resumo

29. Tyler KL, Sokol RJ, Oberhaus SM, et al. Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology. 1998;27:1475-1482.Texto completo  Resumo

30. Steele MI, Marshall CM, Lloyd RE, et al. Reovirus 3 not detected by reverse transcriptase-mediated polymerase chain reaction analysis of preserved tissue from infants with cholestatic liver disease. Hepatology. 1995;21:697-702. Resumo

31. Lorent K, Gong W, Koo KA, et al. Identification of a plant isoflavonoid that causes biliary atresia. Sci Transl Med. 2015;7:286ra67.Texto completo  Resumo

32. Waisbourd-Zinman O, Koh H, Tsai S, et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology. 2016 Sep;64(3):880-93.Texto completo  Resumo

33. Zhao X, Lorent K, Wilkins BJ, et al. Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish. Hepatology. 2016 Sep;64(3):894-907.Texto completo  Resumo

34. Silveira TR, Salzano FM, Donaldson PT, et al. Association between HLA and extrahepatic biliary atresia. J Pediatr Gastroenterol Nutr. 1993;16:114-117. Resumo

35. Kobayashi, H, Puri P, O'Briain DS, et al. Hepatic overexpression of MHC class II antigens and macrophage associated antigens (CD68) in patients with biliary atresia of poor prognosis. J Pediatr Surg. 1997;32:590-593. Resumo

36. Hart MH, Kaufman SS, Vanderhoof JA, et al. Neonatal hepatitis and extrahepatic biliary atresia associated with cytomegalovirus infection in twins. Am J Dis Child. 1991;145:302-305. Resumo

37. Danesino C, Spadoni E, Buzzi A. Familial biliary atresia. Am J Med Genet. 1999;85:195. Resumo

38. Ando K, Miyano T, Fujimoto T, et al. Sibling occurrence of biliary atresia and biliary dilatation. J Pediatr Surg. 1996;31:1302-1304. Resumo

39. Cheng G, Tang CS, Wong EH, et al. Common genetic variants regulating ADD3 gene expression alter biliary atresia risk. J Hepatol. 2013;59:1285-1291. Resumo

40. Garcia-Barceló MM, Yeung MY, Miao XP, et al. Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum Mol Genet. 2010;19:2917-2925.Texto completo  Resumo

41. Chen Y, Gilbert MA, Grochowski CM, et al. A genome-wide association study identifies a susceptibility locus for biliary atresia on 2p16.1 within the gene EFEMP1. PLoS Genet. 2018 Aug;14(8):e1007532.Texto completo  Resumo

42. Ningappa M, So J, Glessner J, et al. The Role of ARF6 in Biliary Atresia. PLoS One. 2015;10(9):e0138381.Texto completo  Resumo

43. Berauer JP, Mezina AI, Okou DT, et al. Identification of Polycystic Kidney Disease 1 Like 1 Gene Variants in Children With Biliary Atresia Splenic Malformation Syndrome. Hepatology. 2019 Sep;70(3):899-910.Texto completo  Resumo

44. Pickett LK, Briggs HC. Biliary obstruction secondary to hepatic vascular ligation in fetal sheep. J Pediatr Surg. 1969;4:95-101. Resumo

45. Klippel CH. A new theory of biliary atresia. J Pediatr Surg. 1972;7:651-654. Resumo

46. Ho CW, Shioda K, Shirasaki K, et al. The pathogenesis of biliary atresia: a morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr. 1993;16:53-60. Resumo

47. Mack CL. The pathogenesis of biliary atresia: evidence for a virus-induced autoimmune disease. Semin Liver Dis. 2007;27:233-242. Resumo

48. Bezerra JA, Tiao G, Ryckman FC, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet. 2002;360:1653-1659. Resumo

49. Bezerra JA. The next challenge in pediatric cholestasis: deciphering the pathogenesis of biliary atresia. J Pediatr Gastroenterol Nutr. 2006;43(suppl 1):S23-S29. Resumo

50. Russo P, Rand EB, Haber BA. Diseases of the biliary tree in infancy and childhood. In: Russo P, Ruchelli ED, Piccoli DA, eds. Pathology of pediatric gastrointestinal and liver disease. New York, NY: Springer; 2004:203-236.

51. Silveira TR, Salzano FM, Howard ER, et al. Extrahepatic biliary atresia and twinning. Braz J Med Biol Res. 1991;24:67-71. Resumo

52. Chardot C, Carton M, Spire-Bendelac N, et al. Epidemiology of biliary atresia in France: a national study 1986-96. J Hepatol. 1999;31:1006-1013. Resumo

53. Noorulla F, Dedon R, Maisels MJ. Association of early direct bilirubin levels and biliary atresia among neonates. JAMA Netw Open. 2019 Oct 2;2(10):e1913321.Texto completo  Resumo

54. Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2017 Jan;64(1):154-68.Texto completo  Resumo

55. Park WH, Choi SO, Lee HJ, et al. A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis. J Paediatr Surg. 1997;32:1555-1559. Resumo

56. Moreira RK, Cabral R, Cowles RA, et al. Biliary atresia: a multidisciplinary approach to diagnosis and management. Arch Pathol Lab Med. 2012 Jul;136(7):746-60.Texto completo  Resumo

57. Humphrey TM, Stringer MD. Biliary atresia: US diagnosis. Radiology. 2007;244:845-851. Resumo

58. Azar G, Beneck D, Lane B, et al. Atypical morphologic presentation of biliary atresia and value of serial liver biopsies. J Pediatr Gastroenterol Nutr. 2002;34:212-215. Resumo

59. Zerbini MC, Gallucci SD, Maezono R, et al. Liver biopsy in neonatal cholestasis: a review on statistical grounds. Mod Pathol. 1997;10:793-799. Resumo

60. Lurie M, Elmalach I, Schuger L, et al. Liver findings in infantile cytomegalovirus infection: similarity to extrahepatic biliary obstruction. Histopathology. 1987;11:1171-1180. Resumo

61. Ishak KG. Inherited metabolic diseases of the liver. Clin Liver Dis. 2002;6:455-479,viii. Resumo

62. Deutsch GH, Sokol RJ, Stathos TH, et al. Proliferation to paucity: evolution of bile duct abnormalities in a case of Alagille syndrome. Pediatr Dev Pathol. 2001;4:559-563. Resumo

63. Peden VH, Witzleben CL, Skelton MA. Total parenteral nutrition. J Pediatr. 1971;78:180-181. Resumo

64. Witzleben CL. Neonatal liver disease. Monogr Pathol. 1981;22:346-368. Resumo

65. Oppenheimer EH, Esterly JR. Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis. J Pediatr. 1975;86:683-689. Resumo

66. Shapira R, Hadzic N, Francavilla R, et al. Retrospective review of cystic fibrosis presenting as infantile liver disease. Arch Dis Child. 1999;81:125-128.Texto completo  Resumo

67. Lefkowitch JH. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and "cholangitis lenta." Hum Pathol. 1982;13:19-24. Resumo

68. Iinuma Y, Narisawa R, Iwafuchi M, et al. The role of endoscopic retrograde cholangiopancreatography in infants with cholestasis. J Pediatr Surg. 2000;35:545-549. Resumo

69. Norton KI, Glass RB, Kogan D, et al. MR cholangiography in the evaluation of neonatal cholestasis: initial results. Radiology. 2002;222:687-691. Resumo

70. Chen SM, Chang MH, Du JC, et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics. 2006;117:1147-1154. Resumo

71. Maki T, Sumasaki R, Matsui A. Biliary atresia: recent findings. Mass screening for biliary atresia. Jpn J Pediatr Surg. 1999;31:242-246.

72. Mushtaq I, Logan S, Morris M, et al. Screening of newborn infants for cholestatic hepatobiliary disease with tandem mass spectrometry. BMJ. 1999;319:471-477.Texto completo  Resumo

73. Schreiber RA, Barker CC, Roberts EA, et al. Biliary atresia: the Canadian experience. J Pediatr. 2007;151:659-665. Resumo

74. Ohi R. Surgery for biliary atresia. Liver. 2001 Jun;21(3):175-82.Texto completo  Resumo

75. Shneider BL, Brown MB, Haber B, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr. 2006;148:467-474. Resumo

76. Altman RP, Lilly JR, Greenfeld J, et al. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg. 1997;226:348-355.Texto completo  Resumo

77. National Institutes of Health. Consensus development conference statement: liver transplantation - June 20-23, 1983. Hepatology. 1984;4(1 suppl):107S-110S. Resumo

78. Barshes NR, Lee TC, Balkrishnan R, et al. Orthotopic liver transplantation for biliary atresia: the U.S. experience. Liver Transpl. 2005;11:1193-1200.Texto completo  Resumo

79. Tyraskis A, Parsons C, Davenport M. Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy. Cochrane Database Syst Rev. 2018 May 14;5:CD008735.Texto completo  Resumo

O uso deste conteúdo está sujeito ao nosso aviso legal